AB0383 Subclinical brain damage in patients with rheumatoid arthritis and its relationship to TNF blocker therapy
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.2315
Abstract: Background RA is a chronic disease with a yet unclarified etiology, which causes the activation of pro-inflammatory pathways that bring about joint and systemic inflammations (1).In recent years, the pathophysiology of brain damage that can… read more here.
Keywords: blocker therapy; tnf blocker; therapy; brain damage ... See more keywords
Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-218304
Abstract: Objectives Antitumour necrosis factor (TNF) therapy has revolutionised treatment of several chronic inflammatory diseases, including spondyloarthritis (SpA). However, TNF inhibitors (TNFi) are not effective in all patients and the biological basis for treatment failure remains… read more here.
Keywords: response profiling; tnf; treatment; immune responses ... See more keywords